Chemed Corp
CHENYSECIK 19584HealthcareFiscal year ends Dec 31
Reports and events: 231 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2909:00 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0000019584-26-000024 |
| 2026-10-2716:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000019584-26-000022 |
| 2026-07-3109:04 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000019584-26-000020 |
| 2026-07-2816:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000019584-26-000018 |
| 2026-05-1910:43 ET | 8-K | 5.07 Shareholder vote results | 0000019584-26-000014 |
| 2026-04-2809:00 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000019584-26-000012 |
| 2026-04-2316:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000019584-26-000010 |
| 2026-04-1309:03 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000019584-26-000008 |
| 2026-04-0609:00 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0000019584-26-000005 |
| 2026-02-2709:36 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001562762-26-000020 |
| 2026-02-2516:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000019584-26-000002 |
| 2025-10-3109:02 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000019584-25-000006 |
| 2025-10-2816:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000019584-25-000004 |
| 2025-07-3109:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001562762-25-000186 |
| 2025-07-2916:56 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001562762-25-000181 |
| 2025-06-2716:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001562762-25-000164 |
| 2025-05-2014:00 ET | 8-K | 5.07 Shareholder vote results | 0001562762-25-000136 |
| 2025-04-2809:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001562762-25-000096 |
| 2025-04-2316:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-25-000088 |
| 2025-04-0709:32 ET | DEF 14A | Proxy statementPeriod 2025-05-19 | 0001562762-25-000072 |
| 2025-04-0109:00 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001562762-25-000070 |
| 2025-02-2809:01 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001562762-25-000038 |
| 2025-02-2616:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-25-000032 |
| 2024-11-0109:00 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001562762-24-000248 |
| 2024-10-2916:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000241 |
| 2024-07-2609:01 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001562762-24-000183 |
| 2024-07-2416:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000179 |
| 2024-05-2109:01 ET | 8-K | 5.07 Shareholder vote results | 0001562762-24-000146 |
| 2024-04-2909:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001562762-24-000106 |
| 2024-04-2416:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000096 |
| 2024-04-1710:15 ET | 8-K | 2.01 Completion of an acquisition or disposition | 0001562762-24-000090 |
| 2024-04-0810:00 ET | DEF 14A | Proxy statementPeriod 2024-04-08 | 0001562762-24-000082 |
| 2024-03-1309:15 ET | 8-K | 8.01 Other events | 0001562762-24-000053 |
| 2024-02-2909:41 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001562762-24-000045 |
| 2024-02-2716:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-24-000036 |
| 2024-02-0110:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001562762-24-000015 |
| 2023-12-1816:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001562762-23-000442 |
| 2023-11-0316:23 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001562762-23-000398 |
| 2023-10-2709:00 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001562762-23-000383 |
| 2023-10-2516:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-23-000378 |
| 2023-07-2809:01 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001562762-23-000299 |
| 2023-07-2616:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-23-000290 |
| 2023-05-1611:47 ET | 8-K | 5.07 Shareholder vote results | 0001562762-23-000250 |
| 2023-04-2809:29 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001562762-23-000183 |
| 2023-04-2616:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-23-000174 |
| 2023-04-0609:00 ET | DEF 14A | Proxy statement | 0001562762-23-000159 |
| 2023-02-2710:14 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001562762-23-000057 |
| 2023-02-2316:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-23-000053 |
| 2022-12-0914:12 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001562762-22-000491 |
| 2022-11-0712:35 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001562762-22-000433 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 09:14 ET. Listed shows no prices and gives no investment advice.